Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients
NCT ID: NCT02122874
Last Updated: 2014-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
60 participants
INTERVENTIONAL
2013-01-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity
NCT05535322
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
NCT06706284
GLP-1/Basal Insulin Combination Therapy
NCT02895672
To Determine Tolerability to Glucagon Infusion in Obese Subjects
NCT02817659
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
NCT04324229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diet
The patients follow only a 1200 Kcal diet
Percutaneous Neurostimulation (PENS) of dermatome T7
The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet
1200 Kcal diet
Diet +PENS dermatome T7
The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet
Percutaneous Neurostimulation (PENS) of dermatome T7
The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous Neurostimulation (PENS) of dermatome T7
The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet
1200 Kcal diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 2 diabetes mellitus
* Treatment with Metformin
Exclusion Criteria
* Endocrinological disorders causing diabetes mellitus
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General Universitario Elche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaime Ruiz-Tovar, MD, PhD
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital Elche
Elche, Alicante, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.